文献速递胃肠外科围术期管理与 ERAS

减重手术前常规内镜检查的临床价值:885例11年回顾性分析

The utility of endoscopy prior to bariatric surgery: an 11-year retrospective analysis of 885 patients.
PubMed 文献 · Surg Endosc · 2022-08-08

该研究回顾性分析了885例2011年3月至2022年2月期间接受初次减重手术的患者,评估术前常规食管胃十二指肠镜(p-EGD)的诊断价值。结果显示83.2%的患者存在至少一项异常内镜发现,其中食管裂孔疝占43.1%,胃炎占32.4%,幽门螺杆菌感染占9.8%,Barrett食管占2.7%。结论认为术前EGD常能发现具有临床意义的异常,减重手术的术前评估应与前肠手术的现行推荐保持一致。

要点

  • 减重手术患者术前常规EGD异常发现率高达83.2%。
  • 食管裂孔疝(43.1%)和胃炎(32.4%)是最常见的异常发现。
  • 术前EGD可指导抑酸治疗和NSAIDs停用等围术期管理决策。

核心结论

  • 减重人群中胃食管反流病及相关病理常见,术前EGD常可发现具有临床意义的上消化道病变。
  • 鉴于肥胖患者术前内镜异常发现率高,减重手术的术前评估应与前肠手术的现行推荐保持一致。

研究设计与样本

  • 单中心大学附属医院减重手术项目的回顾性病历审查。
  • 纳入2011年3月至2022年2月期间接受初次减重手术的885例患者。
  • 回顾临床病史、人口学资料及术前EGD报告中的异常发现。

主要发现

  • 885例患者中83.2%存在至少一项异常EGD发现。
  • 54.7%的患者有心灼热、反流或GERD病史。
  • EGD显示43.1%的患者存在疝(I型40.6%;II型0.5%;III型2.1%)。
  • 68.0%的患者接受了活检,活检者中胃炎32.4%、食管炎8.0%、嗜酸性食管炎4.7%、十二指肠炎2.7%。
  • 6.7%的患者发现溃疡,活检病理提示幽门螺杆菌感染9.8%、Barrett食管2.7%。

关键数值与推荐

  • 常规p-EGD后,11.2%的患者开始使用PPI,8.3%被建议停用NSAIDs。

临床怎么用

  • 对减重手术患者术前应常规行EGD以筛查GERD相关病理及解剖异常。
  • 根据EGD结果个体化调整围术期用药,如启动PPI或停用NSAIDs。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Our aim was to evaluate the diagnostic yield of routine preoperative esophagogastroduodenoscopy (p-EGD) in patients undergoing bariatric surgery. Many medical problems that are common in patients with obesity, including gastroesophageal reflux disease (GERD) and hiatal hernias, have important implications for patients undergoing bariatric surgery. While p-EGD is considered standard of care prior to antireflux surgery, the role of p-EGD in bariatric surgery patients remains controversial. METHODS AND PROCEDURES: We performed a retrospective chart review of 885 patients who underwent primary bariatric surgery at a university hospital-based bariatric surgery program between March 2011 and February 2022. Clinical history, demographics, and preoperative EGD reports were reviewed for abnormal findings. RESULTS: Of the 885 patients evaluated in this study, one or more abnormal EGD findings were observed in 83.2% of patients. More than half of our patients (54.7%) presented with history of heartburn, reflux, or GERD. EGD findings demonstrated a hernia in 43.1% of patients [(Type I: 40.6%; Type II: 0.5%; Type III: 2.1%)]. 68.0% of patients were biopsied. Among patients who were biopsied, other findings included gastritis (32.4%), esophagitis (8.0%), eosinophilic esophagitis (4.7%), or duodenitis (2.7%). We found ulcers in 6.7% of patients. Pathology was consistent with H. pylori in 9.8% of biopsies taken and consistent with BE in 2.7%. Following routine p-EGD, 11.2% of patients were placed on PPI and 8.3% were recommended to stop NSAIDs. CONCLUSION: Gastroesophageal reflux disease and associated pathology are common in the bariatric population. Preoperative EGD in patients undergoing bariatric surgery frequently identifies clinically significant UGI pathology. This may have important implications for medical and surgical management. Given the rate of abnormal preoperative endoscopic findings in obese patients, the work-up for bariatric surgery should align with the current recommendations for foregut surgery.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Chen J, Razzouk J, Martinez P, et al. The utility of endoscopy prior to bariatric surgery: an 11-year retrospective analysis of 885 patients. Surg Endosc. 2022. PMID: 35941309. doi:10.1007/s00464-022-09485-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。